NCT01959971View on ClinicalTrials.gov

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Hypercholesterolemia
Interventions
DRUG

alirocumab

"Pharmaceutical form:Solution for injection~Route of administration: Subcutaneous"

DRUG

Placebo

"Pharmaceutical form:Solution for injection~Route of administration: Subcutaneous"

Trial Locations (1)

10032

Investigational Site Number 840001, New York

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT01959971 - Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol | Biotech Hunter | Biotech Hunter